All Updates

All Updates

icon
Filter
Partnerships
Accelerated Biosciences and Spanios partner to advance therapeutic design in solid tumor cancers
Precision Medicine
May 16, 2024
Last week:
Geographic expansion
Partnerships
Lemonade partners with Homesite to expand home insurance services
InsurTech: Personal Lines
Jun 14, 2024
Funding
BayaniPay raises USD 3 million in seed funding to expand payment solutions
Neobanks
Jun 14, 2024
Partnerships
Carbonfuture and Swiss Re partner for long-term carbon removal through biochar
Carbon Management Software
Jun 13, 2024
Funding
Sidekick raises GBP 8.5 million in seed and debt funding to support expansion
Retail Trading Infrastructure
Jun 13, 2024
Partnerships
Climatiq and Epicor partner to reduce CO2 emissions in supply chains
Carbon Management Software
Jun 13, 2024
Product updates
EHang's pilotless eVTOL aircraft concludes first flight launch in Saudi Arabia
Passenger eVTOL Aircraft
Jun 13, 2024
Partnerships
Skyports partners with Unified Aviation to accelerate global network release
Passenger eVTOL Aircraft
Jun 13, 2024
Industry news
Partnerships
USSF chooses Blue Origin, SpaceX, and ULA for ~USD 5.6 billion Pentagon launch contracts
Space Travel and Exploration Tech
Jun 13, 2024
Funding
AnyCreek raises USD 1.8 million in seed funding to enhance platform and expand into new markets
Travel Tech
Jun 13, 2024
Funding
Zeta Labs raises USD 2.9 million in pre-seed funding to develop autonomous AI agent
Generative AI Applications
Jun 13, 2024
Precision Medicine

Precision Medicine

May 16, 2024

Accelerated Biosciences and Spanios partner to advance therapeutic design in solid tumor cancers

Partnerships

  • Accelerated Biosciences has formed a partnership with Spanios tumor therapy research firm to develop oncology therapeutics from its human trophoblast stem cell (hTSC) platform.

  • The partnership aims to bring together Spanios' COMPASS platforms and patient-derived tumor models with AcceleratedBio's hTSC platform to improve therapy designs for solid tumor cancers. Accelerated Biosciences will provide ethically sourced pluripotent stem cells with potential use in wide-ranging medical and biotech applications. Spanios, with its expertise in tumoroid research and ability to simulate preclinical therapeutic performance rapidly, will generate clinically relevant data for these stem cells. This collaboration aims to enhance cell-based therapies, specifically for challenging cancers such as Ovarian and Colorectal.

  • Spanios is a precision oncology company using its proprietary patient-derived 3D tumoroid (PDT) platform to study the biological complexity of solid tumors in order to develop treatments. The platform creates a replica of host tumor environments with customizable testing conditions to study drug responses and efficacy.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.